NHAS
LEGN icon

Novo Holdings A/S’s Legend Biotech LEGN Stock Holding History

Novo Holdings A/S’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-279,676
Closed -$11.5M – 52
2021
Q2 		$11.5M Buy
279,676
+25,500
+10% +$867K 0.51% 34
2021
Q1 		$7.38M Buy
+254,176
New +$6.93M 0.3% 42

Other funds holding LEGN

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Novo Holdings A/S's LEGN Position: Q3 2021 in Review

Novo Holdings A/S sold out of Legend Biotech (LEGN) in Q3 2021, closing a stake of 279,676 shares — an estimated $11.5M sold.

Novo Holdings A/S first reported a position in LEGN in Q1 2021 and held it in 2 quarters. The position peaked at $11.5M in Q2 2021. 88 funds tracked by Wall St. Rank hold LEGN as of Q3 2021.

  • Novo Holdings A/S reported no remaining Legend Biotech position as of Q3 2021 after selling out during the quarter.
  • Novo Holdings A/S sold 279,676 Legend Biotech shares in Q3 2021, an estimated $11.5M.
  • Novo Holdings A/S first reported a position in Legend Biotech in Q1 2021 and held it in 2 quarters.
  • Novo Holdings A/S's Legend Biotech position peaked at $11.5M in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2021.

Based on Novo Holdings A/S's 13F filing for Q3 2021, filed 15 Nov 2021.